Bernard M. Fine

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

Elizabeth A. Punnoose, Siminder Atwal, Weiqun Liu et al. · Clinical Cancer Research · 2012 · 417 citations

Medicine, Nuclear Medicine, Oncology +17

Molecular Biomarker Analyses Using Circulating Tumor Cells

Elizabeth A. Punnoose, Siminder Atwal, Jill M. Spoerke et al. · PLoS ONE · 2010 · 297 citations · Full text

Medicine, Cell Biology, Oncology +17

A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients

Hongyue Dai, Laura van’t Veer, John R. Lamb et al. · Cancer Research · 2005 · 261 citations · Full text

Medicine, Biology, Oncology +17

Smoothed orientational order profile of lipid bilayers by 2H-nuclear magnetic resonance

Michel Lafleur, Bernard M. Fine, Edward Sternin et al. · Biophysical Journal · 1989 · 232 citations · Full text

Natural Sciences, Biophysics, Physics +16